Exploring the Antitumor Mechanism of High-Dose Cytarabine through the Metabolic Perturbations of Ribonucleotide and Deoxyribonucleotide in Human Promyelocytic Leukemia HL-60 Cells-Reference-Cited by-同舟云学术

Exploring the Antitumor Mechanism of High-Dose Cytarabine through the Metabolic Perturbations of Ribonucleotide and Deoxyribonucleotide in Human Promyelocytic Leukemia HL-60 Cells

Published:2017-03-21 Issue:3 Volume:22 Page:499
ISSN:1420-3049
Container-title:Molecules
language:en
Short-container-title:Molecules

Author:

Li Zheng,Guo Jian-Ru,Chen Qian-Qian,Wang Cai-Yun,Zhang Wei-Jia,Yao Mei-Cun,Zhang Wei

Funder

Macao Science and Technology Development Fund

Publisher

MDPI AG

Subject

Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science

Link

http://www.mdpi.com/1420-3049/22/3/499/pdf

Reference28 articles.

1. Genetic Abnormalities and Challenges in the Treatment of Acute Myeloid Leukemia

2. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

3. A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study

4. High dose cytosine arabinoside (HDARAC) in refractory acute leukemia

5. Superiority of high-dose over intermediate-dose cytosine arabinoside in the treatment of patients with high-risk acute myeloid leukemia: results of an age-adjusted prospective randomized comparison

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CSE1L Silencing Enhances Cytarabine-mediated Cytotoxicity in Acute Myeloid Leukemia;Indian Journal of Hematology and Blood Transfusion;2024-05-27

2. Prediction of miRNA‑mRNA network regulating the migration ability of cytarabine‑resistant HL60 cells;Biomedical Reports;2023-12-13

3. Oral cytarabine ocfosfate pharmacokinetics and assessment of leukocyte biomarkers in normal dogs;Journal of Veterinary Internal Medicine;2023-09-05

4. Nucleoside-based anticancer drugs: Mechanism of action and drug resistance;Biochemical Pharmacology;2023-09

5. Magnetosomes as Potential Nanocarriers for Cancer Treatment;Current Drug Delivery;2023-06-19